Post Profile

Medical cannabis significantly safer for elderly with chronic pain than Opioids

A new study found cannabis therapy is safe and efficacious for elderly patients who are seeking to address cancer symptoms, Parkinson's disease, post-traumatic stress disorder, ulcerative colitis, Crohn's disease, multiple sclerosis, and other medical issues. After six months, more than 18 percent of patients surveyed had stopped using opioid analgesics or had reduced their dosage.
read more


Related Posts

Metabolite of multiple sclerosis drug could be safe, effective therapy for Parkinson's disease

Academics / General Science : ScienceDaily: Science Society

The metabolite of a drug that is helping patients battle multiple sclerosis appears to significantly slow the onset of Parkinson's disease, researchers say.

New Study Finds Specialized Support Programs Can Increase Treatment Adherence And Persistence, Reduce Relapses For People With Multiple Sclerosis

Health : Medical News Today

A new study reveals that multiple sclerosis (MS) patients enrolled in a seven-month disease therapy management (DTM) program show greater adherence to injectable MS medications and treatment persistence than patients who receive inj...

Stress Reduction Therapy Could Significantly Help Multiple Sclerosis Patients

Health : Medical News Today

A new study by Northwestern Medicine research, published in the journal Neurology, discovered that a weekly stress management program for patients with multiple sclerosis (MS) prevented the development of new brain lesions, which of...

How to Determine Whether a Patient is Safe to Drive

Health : Newswise Medical News

Driver rehabilitation provides a comprehensive evaluation on whether a patient can safely drive a car. It is intended for elderly patients and patients with stroke, brain injury, Parkinson's disease, multiple sclerosis, low vision, ...

New clinical trial data: Multiple sclerosis drug candidate also shows promise for ulcerative colitis

Academics / General Science : ScienceDaily: Science Society

Positive new clinical data have been released on a drug candidate for ulcerative colitis. In the study, 199 patients with active, moderate to severe disease, the drug candidate RPC1063 has potential to significantly improve the trea...


Copyright © 2016 Regator, LLC